CVE-2025-26683: CWE-285: Improper Authorization in Microsoft Azure Playwright
Improper authorization in Azure Playwright allows an unauthorized attacker to elevate privileges over a network.
AI Analysis
Technical Summary
CVE-2025-26683 is a high-severity vulnerability classified under CWE-285 (Improper Authorization) affecting Microsoft Azure Playwright, a cloud-based service used for browser automation and testing. The flaw allows an unauthorized attacker to elevate privileges over a network, meaning that an attacker without prior authentication can exploit this vulnerability remotely. The CVSS v3.1 base score is 8.1, indicating a high impact on confidentiality, integrity, and availability. The vector details (AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H) show that the attack can be performed remotely over the network without any privileges or user interaction, but requires high attack complexity. Successful exploitation could lead to full compromise of the affected Azure Playwright environment, allowing attackers to execute arbitrary commands, access sensitive data, modify or delete resources, and disrupt services. No specific affected versions are listed, which suggests the vulnerability may affect all current versions or the product generally. No patches or known exploits in the wild have been reported yet. Given Azure Playwright's role in automated testing and development workflows, this vulnerability could be leveraged to compromise development pipelines, inject malicious code, or gain footholds in cloud environments.
Potential Impact
For European organizations, the impact of CVE-2025-26683 is significant due to the widespread adoption of Microsoft Azure services across Europe, including Azure Playwright for automated testing and DevOps processes. Exploitation could lead to unauthorized access to sensitive intellectual property, customer data, and internal development environments, potentially causing data breaches and operational disruptions. This could also undermine trust in cloud-based development tools and delay software delivery. Organizations in regulated sectors such as finance, healthcare, and critical infrastructure could face compliance violations and reputational damage. The ability to elevate privileges remotely without authentication increases the risk of large-scale attacks, especially in multi-tenant cloud environments common in Europe. Additionally, disruption of automated testing workflows could delay patching and deployment of security fixes, compounding risk exposure.
Mitigation Recommendations
1. Monitor Microsoft’s official security advisories closely for patches or updates addressing CVE-2025-26683 and apply them immediately upon release. 2. Restrict network access to Azure Playwright services using network segmentation, firewalls, and Azure Private Link to limit exposure to trusted IPs and internal networks only. 3. Implement strict role-based access controls (RBAC) and least privilege principles within Azure environments to minimize the impact of any potential compromise. 4. Enable comprehensive logging and monitoring of Azure Playwright usage and authentication attempts to detect anomalous activities early. 5. Use Azure Security Center and other cloud security posture management tools to continuously assess and remediate configuration weaknesses. 6. Consider isolating critical development and testing environments from production and sensitive data stores to contain potential breaches. 7. Educate development and security teams about this vulnerability and encourage rapid incident response readiness. 8. If possible, temporarily disable or limit use of Azure Playwright until a patch is available, especially in high-risk environments.
Affected Countries
Germany, France, United Kingdom, Netherlands, Sweden, Italy, Spain, Poland
CVE-2025-26683: CWE-285: Improper Authorization in Microsoft Azure Playwright
Description
Improper authorization in Azure Playwright allows an unauthorized attacker to elevate privileges over a network.
AI-Powered Analysis
Technical Analysis
CVE-2025-26683 is a high-severity vulnerability classified under CWE-285 (Improper Authorization) affecting Microsoft Azure Playwright, a cloud-based service used for browser automation and testing. The flaw allows an unauthorized attacker to elevate privileges over a network, meaning that an attacker without prior authentication can exploit this vulnerability remotely. The CVSS v3.1 base score is 8.1, indicating a high impact on confidentiality, integrity, and availability. The vector details (AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H) show that the attack can be performed remotely over the network without any privileges or user interaction, but requires high attack complexity. Successful exploitation could lead to full compromise of the affected Azure Playwright environment, allowing attackers to execute arbitrary commands, access sensitive data, modify or delete resources, and disrupt services. No specific affected versions are listed, which suggests the vulnerability may affect all current versions or the product generally. No patches or known exploits in the wild have been reported yet. Given Azure Playwright's role in automated testing and development workflows, this vulnerability could be leveraged to compromise development pipelines, inject malicious code, or gain footholds in cloud environments.
Potential Impact
For European organizations, the impact of CVE-2025-26683 is significant due to the widespread adoption of Microsoft Azure services across Europe, including Azure Playwright for automated testing and DevOps processes. Exploitation could lead to unauthorized access to sensitive intellectual property, customer data, and internal development environments, potentially causing data breaches and operational disruptions. This could also undermine trust in cloud-based development tools and delay software delivery. Organizations in regulated sectors such as finance, healthcare, and critical infrastructure could face compliance violations and reputational damage. The ability to elevate privileges remotely without authentication increases the risk of large-scale attacks, especially in multi-tenant cloud environments common in Europe. Additionally, disruption of automated testing workflows could delay patching and deployment of security fixes, compounding risk exposure.
Mitigation Recommendations
1. Monitor Microsoft’s official security advisories closely for patches or updates addressing CVE-2025-26683 and apply them immediately upon release. 2. Restrict network access to Azure Playwright services using network segmentation, firewalls, and Azure Private Link to limit exposure to trusted IPs and internal networks only. 3. Implement strict role-based access controls (RBAC) and least privilege principles within Azure environments to minimize the impact of any potential compromise. 4. Enable comprehensive logging and monitoring of Azure Playwright usage and authentication attempts to detect anomalous activities early. 5. Use Azure Security Center and other cloud security posture management tools to continuously assess and remediate configuration weaknesses. 6. Consider isolating critical development and testing environments from production and sensitive data stores to contain potential breaches. 7. Educate development and security teams about this vulnerability and encourage rapid incident response readiness. 8. If possible, temporarily disable or limit use of Azure Playwright until a patch is available, especially in high-risk environments.
Affected Countries
For access to advanced analysis and higher rate limits, contact root@offseq.com
Technical Details
- Data Version
- 5.1
- Assigner Short Name
- microsoft
- Date Reserved
- 2025-02-12T22:35:41.551Z
- Cisa Enriched
- true
- Cvss Version
- 3.1
- State
- PUBLISHED
Threat ID: 682cd0f81484d88663aeb3ae
Added to database: 5/20/2025, 6:59:04 PM
Last enriched: 7/11/2025, 4:04:49 AM
Last updated: 8/11/2025, 9:03:30 PM
Views: 31
Related Threats
CVE-2025-8690: CWE-79 Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') in addix Simple Responsive Slider
MediumCVE-2025-8688: CWE-79 Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') in ebernstein Inline Stock Quotes
MediumCVE-2025-8685: CWE-79 Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') in emilien Wp chart generator
MediumCVE-2025-8621: CWE-80 Improper Neutralization of Script-Related HTML Tags in a Web Page (Basic XSS) in odn Mosaic Generator
MediumCVE-2025-8568: CWE-79 Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') in prabode GMap Generator
MediumActions
Updates to AI analysis are available only with a Pro account. Contact root@offseq.com for access.
External Links
Need enhanced features?
Contact root@offseq.com for Pro access with improved analysis and higher rate limits.